Artritter

Van Venrooij WJ, van Beers JBC, Pruij GJM. Anti-CCP antibody, a marker for the early detection of rheumatoid arthritis. Ann NY Acad Sci 2008;1143:268-285

Van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis. Arthritis Rheum 2004;50:709-15

Horton, DB, Scott FI, Heynes K, Putt ME, Rose CD, Lewis JD, Strom BL: Antibiotic exposure and juvenile idiopathic arthritis: A case-control study. Pediatrics Vol 136, num. 2, Aug 2015

Kiely PDW, Brown AK, Edwards CJ, et al. Contemporary treatment principles for early rheumatoid arthritis: a consensus statement. Rheumatology 2009;48:765-72

Smolen JS, Aletaha D, Bijlsma JWJ et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010; 69: 631-637

Flatø B, Vinje O. Epidemiologien ved juvenil idiopatisk artritt og andre artritter i barnealderen. Norsk epidemiologi 2008;18:93-8

Eilertsen GØ, Becker-Merok A, Nossent JC. The influence of the 1997 updated classification criteria for systemic lupus erythematosus: epidemiology, disease presentation, and patient management. J Rheumatol 2009;36:552-9

Bertsias G, Ioannidis JPA, Boletis J, et al. EULAR recommendations for the management of systemic lupus erythematosus. Reports of a task force of the EULAR standing committee for international clinical studies including therapeutics. Ann Rheum Dis 2008;67:195-205

Brun JG, Jonsson R. Sjögrens syndrom. Norsk epidemiologi 2008; 18 (1): 67-72

Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American European Consensus Group. Ann Rheum Dis 2002;61:554-8

Kowal-Bielecka O, Landewe R, Avouac J et al. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR scleroderma trials and research group (EUSTAR). Ann Rheum Dis 2009;68:620-8

Chakravarty K, Elgabani SH, Scott DG, Merry P. A district audit on the management of polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol 1994;33:152-6

Salvarini C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet 2008;372:234-45

Mukhtyar C, Guillevin L, Cid MC, et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2009;68:318-23

Zhang W, Doherty M, Bardin T et al. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT). Ann Rheum Dis 2006;65:1312-24

Pascual E, Sivera F. Therapeutic advanced in gout. Curr Opin Rheumatol 2007;19:122-7

Thabet MM et al, Arthritis Res Ther 2009; 11:R155 og De Rooy DPC et al, Rheumatology 2011: 50, 93-100.

Hannu T, Mattila L, Siitonen A, Leirisalo-Repo M. Reactive arthritis attributable to Shigella infection: a clinical and epidemiological nationwide study. Ann Rheum Dis 2005;64:594-598

Townes JM. Reactive Arthritis after Enteric Infections in the United States: The Problem of Definition. Clinical Infectious Diseases 2010;50:247-54

Watts RA, Scott DGI. Recent developements in the classification and assessment of vasculitis. Best Practice&Research Clinical Rheumatology 2009;23:429-43

Pagnoux C et al. Clinical Features and Outcomes in 348 Patients with Polyartheritis Nodosa. Arthritis Rheum 2010;62:616-26

Goodman SM, Springer B, Guyatt G, et al.  2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. J Arthroplasty. 2017 Jun 16. pii: S0883-5403(17)30401-1. doi: 10.1016/j.arth.2017.05.001.  (Systematic Review)  PMID: 28629905

Artrose

Slatkowsky-Christensen B, Grotle M. Artrose i Norge. Norsk epidemiologi 2008;18:99-106

Bijlsma JWJ, Lafeber FPJG. Glucosamine sulfate in osteoarthritis. The jury is still out. Editorial. Ann Intern Med 2008;148:315-6

Jordan KM et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003;62:1145-55

Linda Fernandes, Kåre B Hagen et al EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis Ann Rheum Dis doi:10.1136/annrheumdis-2012-202745  

Singh JA, Noorbalooch S, MacDonald R, Maxwell LJ: Chondroitin for osteoarthritis. Editorial Group: Cochrane Musculoskeletal Group. Published Online: 28 JAN 2015 Assessed as up-to-date: 14 NOV 2013 DOI: 10.1002/14651858.CD005614.pub2

2018 update of the EULAR recommendations for the management of hand osteoarthritis Annals of the Rheumatic Disease 2018; 10.1136/annrheumdis-2018-213826 

Degenerative leddsykdommer

Norsk fysikalsk medisin, 2. utg. Red: Niels Gunnar Juel. Fagbokforlaget 2014

EULAR evidence-based recommendations for the management of fibromyalgia syndrome. S F Carville et al. Ann Rheum Dis 2008;67:536–541.

UpToDate (Helsebiblioteket)

Osteoporose

Allen CS, Yeung JHS, Vandermeer B, Homik J. Bisphosphonates for steroid‐induced osteoporosis. Cochrane Database of Systematic Reviews 2016, Issue 10. Art. No.: CD001347. DOI: 10.1002/14651858.CD001347.pub2. 

Compston J, Cooper A, Cooper C, et al. UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos. 2017;12(1):43. doi:10.1007/s11657-017-0324-5 

Iolascon G, Moretti A, Toro G, Gimigliano F, Liguori S, Paoletta M. Pharmacological Therapy of Osteoporosis: What's New? Clin Interv Aging. 2020 Mar 26;15:485-491. doi: 10.2147/CIA.S242038. PMID: 32273690; PMCID: PMC7105363. 

Kanis JA, Cooper C, Rizzoli R, Reginster JY; Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF). European guidance for the diagnosis and management of osteoporosis in postmenopausal women [published correction appears in Osteoporos Int. 2020 Jan;31(1):209] [published correction appears in Osteoporos Int. 2020 Apr;31(4):801]. Osteoporos Int. 2019;30(1):3–44. doi:10.1007/s00198-018-4704-5 

Marjoribanks J, Farquhar C, Roberts H, Lethaby A, Lee J. Long‐term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database of Systematic Reviews 2017, Issue 1. Art. No.: CD004143. DOI: 10.1002/14651858.CD004143.pub5.